WOBURN, Mass., July 20, 2023 (GLOBE NEWSWIRE) — NeuroMetrix, Inc. (Nasdaq: NURO) introduced at this time that it plans to challenge its Q2 2023 enterprise and monetary highlights earlier than the opening of the market on July 27, 2023. The Firm will host a convention name at 8:00 a.m., Japanese Time on July 27, 2023.
For individuals who want to entry the Q2 2023 Convention Name reside through phone and have the ability to ask questions, please register prematurely right here. Upon registering, a dial-in and distinctive PIN might be offered on display screen and through e-mail to hitch the decision. An audio-only webcast of the decision, together with the earnings press launch and accompanying condensed monetary statements, could also be accessed within the Traders part of the Firm’s web site at www.NeuroMetrix.com. Following the convention name, a replay of the decision might be out there for one yr on the Firm’s Traders part of the web site.
NeuroMetrix is a business stage healthcare firm that develops and commercializes neurotechnology gadgets to handle unmet wants within the persistent ache and diabetes markets. The Firm’s merchandise are wearable or hand-held medical gadgets enabled by proprietary consumables and software program options that embrace cellular apps, enterprise software program and cloud-based programs. The Firm has two business manufacturers. Quell® is a wearable neuromodulation platform. DPNCheck® is a point-of-care screening take a look at for peripheral neuropathy. For extra info, go to www.NeuroMetrix.com.
Thomas T. Higgins
SVP and Chief Monetary Officer
Supply: NeuroMetrix, Inc.